AA
DVAX

AlphaCentric Advisors’s Dynavax Technologies DVAX Stock Holding History

AlphaCentric Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-201,500
Closed -$2.24M – 226
2024
Q3 		$2.24M Buy
201,500
+71,500
+55% +$788K 1.67% 13
2024
Q2 		$1.46M Buy
130,000
+7,500
+6% +$87.3K 1.08% 27
2024
Q1 		$1.52M Buy
122,500
+22,500
+23% +$293K 0.92% 37
2023
Q4 		$1.4M Sell
100,000
-10,000
-9% -$139K 0.94% 38
2023
Q3 		$1.62M Hold
110,000
– – 0.92% 36
2023
Q2 		$1.42M Buy
110,000
+2,500
+2% +$28.5K 0.79% 48
2023
Q1 		$1.05M Buy
107,500
+71,500
+199% +$763K 0.73% 45
2022
Q4 		$383K Hold
36,000
– – 0.38% 87
2022
Q3 		$376K Buy
+36,000
New +$469K 0.39% 68
2021
Q1 		– Sell
-14,500
Closed -$65K – 212
2020
Q4 		$65K Buy
14,500
+13,900
+2,317% +$62.9K 0.03% 165
2020
Q3 		$3K Buy
600
+300
+100% +$2.14K ﹤0.01% 162
2020
Q2 		$3K Buy
+300
New +$1.52K ﹤0.01% 142

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCentric Advisors's DVAX Position: Q4 2024 in Review

AlphaCentric Advisors sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 201,500 shares — an estimated $2.24M sold.

AlphaCentric Advisors first reported a position in DVAX in Q2 2020 and held it in 12 quarters. The position peaked at $2.24M in Q3 2024. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • AlphaCentric Advisors reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • AlphaCentric Advisors sold 201,500 Dynavax Technologies shares in Q4 2024, an estimated $2.24M.
  • AlphaCentric Advisors first reported a position in Dynavax Technologies in Q2 2020 and held it in 12 quarters.
  • AlphaCentric Advisors's Dynavax Technologies position peaked at $2.24M in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.